KSE - Delayed Quote KRW

Cosmax, Inc. (192820.KS)

Compare
166,800.00
+15,600.00
+(10.32%)
At close: 3:30:03 PM GMT+9
Loading Chart for 192820.KS
DELL
  • Previous Close 151,200.00
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 208,000.00
  • Volume 0
  • Avg. Volume 102,328
  • Market Cap (intraday) 1.892T
  • Beta (5Y Monthly) 0.54
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Mar 5, 2025 - Mar 20, 2025
  • Forward Dividend & Yield 500.00 (0.38%)
  • Ex-Dividend Date Dec 27, 2023
  • 1y Target Est 190,263.16

Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally. The company operates through Cosmetic Business segment, Custom Cosmetic, and other Business segments. The company offers skincare products under the Capsule+, IS-LCE, CeraPresso, Emulixir, Foamology, IRPT, and Solar Clear brands; base-make up under the Air Cloud, and skin fabric names; and make up under the Xfine, JellTeX, ARTCOTTA, Bi-Coat, creamline, Thixolash, and CRYSTAL PRISM brands; oriental medicine under the Ginsenology name; and fragrance under the Scenteritage brand, as well as hair care products. The company was formerly known as Miroto Korea and changed its name to Cosmax, Inc. in 1994. Cosmax, Inc. was founded in 1992 and is headquartered in Hwaseong-si, South Korea.

www.cosmax.com

1,390

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 192820.KS

View More

Performance Overview: 192820.KS

Trailing total returns as of 1/16/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

192820.KS
11.87%
KOSPI Composite Index
5.33%

1-Year Return

192820.KS
43.92%
KOSPI Composite Index
1.20%

3-Year Return

192820.KS
113.62%
KOSPI Composite Index
13.50%

5-Year Return

192820.KS
96.68%
KOSPI Composite Index
12.43%

Compare To: 192820.KS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 192820.KS

View More

Valuation Measures

As of 1/15/2025
  • Market Cap

    1.72T

  • Enterprise Value

    2.21T

  • Trailing P/E

    21.81

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.84

  • Price/Book (mrq)

    3.88

  • Enterprise Value/Revenue

    1.08

  • Enterprise Value/EBITDA

    9.66

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.69%

  • Return on Assets (ttm)

    5.41%

  • Return on Equity (ttm)

    13.06%

  • Revenue (ttm)

    1.97T

  • Net Income Avi to Common (ttm)

    72.86B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    333.52B

  • Total Debt/Equity (mrq)

    138.37%

  • Levered Free Cash Flow (ttm)

    151.23B

Research Analysis: 192820.KS

View More

People Also Watch